Authors' Reply: Why Valganciclovir Should Not Be Indicated for Liver Recipients and High-Dose Acyclovir Should Not Be Removed From International Cytomegalovirus Guidelines

被引：0
|
作者：
Kotton, Camille Nelson [1 ]
Humar, Atul [2 ]
机构：
[1] Massachusetts Gen Hosp, Div Infect Dis, Boston, MA 02114 USA
[2] Univ Alberta, Dept Med, Katz Rexall Ctr Hlth Res, Edmonton, AB, Canada
来源：
TRANSPLANTATION | 2011年 / 91卷 / 01期
关键词：
EFFICACY; DISEASE;
D O I：
10.1097/TP.0b013e3181fc8958
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
引用
收藏
页码：E10 / E10
页数：1
相关论文
共 8 条
  • [1] Why Valganciclovir Should Not Be Indicated for Liver Recipients and High-Dose Acyclovir Should Not Be Removed From International Cytomegalovirus Guidelines
    Kalil, Andre C.
    Florescu, Diana F.
    [J]. TRANSPLANTATION, 2011, 91 (01) : E8 - E9
  • [2] A PROSPECTIVE RANDOMIZED TRIAL COMPARING - SEQUENTIAL, GANCICLOVIR HIGH-DOSE ACYCLOVIR TO HIGH-DOSE ACYCLOVIR FOR PREVENTION OF CYTOMEGALOVIRUS DISEASE IN ADULT LIVER-TRANSPLANT RECIPIENTS
    MARTIN, M
    MANEZ, R
    LINDEN, P
    ESTORES, D
    TORRECISNEROS, J
    KUSNE, S
    ONDICK, L
    PTACHCINSKI, R
    IRISH, W
    KISOR, D
    FELSER, I
    RINALDO, C
    STIEBER, A
    FUNG, J
    HO, MT
    SIMMONS, R
    STARZL, T
    [J]. TRANSPLANTATION, 1994, 58 (07) : 779 - 785
  • [3] HIGH-DOSE ORAL ACYCLOVIR REDUCES THE INCIDENCE OF CYTOMEGALOVIRUS-INFECTION IN LIVER-TRANSPLANT RECIPIENTS
    MOLLISON, LC
    RICHARDS, MJ
    JOHNSON, PDR
    HAYES, K
    MUNCKHOF, WJ
    JONES, RM
    DABKOWSKI, PD
    ANGUS, PW
    [J]. JOURNAL OF INFECTIOUS DISEASES, 1993, 168 (03): : 721 - 724
  • [4] RANDOMIZED COMPARISON OF GANCICLOVIR AND HIGH-DOSE ACYCLOVIR FOR LONG-TERM CYTOMEGALOVIRUS PROPHYLAXIS IN LIVER-TRANSPLANT RECIPIENTS
    WINSTON, DJ
    WIRIN, D
    SHAKED, A
    BUSUTTIL, RW
    [J]. LANCET, 1995, 346 (8967): : 69 - 74
  • [5] HIGH-DOSE ACYCLOVIR COMPARED WITH SHORT-COURSE PREEMPTIVE GANCICLOVIR THERAPY TO PREVENT CYTOMEGALOVIRUS DISEASE IN LIVER-TRANSPLANT RECIPIENTS - A RANDOMIZED TRIAL
    SINGH, N
    YU, VL
    MIELES, L
    WAGENER, MM
    MINER, RC
    GAYOWSKI, T
    [J]. ANNALS OF INTERNAL MEDICINE, 1994, 120 (05) : 375 - 381
  • [6] High-dose interferon, sentinel lymph node biopsy and the U.K. guidelines for cutaneous melanoma: reply from authors
    Bishop, JAN
    Corrie, PG
    Evans, J
    Gore, ME
    Hall, PN
    Kirkham, N
    Roberts, DLL
    Anstey, AV
    Barlow, RJ
    Cox, NH
    [J]. BRITISH JOURNAL OF DERMATOLOGY, 2002, 147 (04) : 834 - 835
  • [7] RANDOMIZED TRIAL OF GANCICLOVIR FOLLOWED BY HIGH-DOSE ORAL ACYCLOVIR VS GANCICLOVIR ALONE IN THE PREVENTION OF CYTOMEGALOVIRUS DISEASE IN PEDIATRIC LIVER-TRANSPLANT RECIPIENTS - PRELIMINARY-ANALYSIS
    GREEN, M
    REYES, J
    NOUR, B
    BEATTY, D
    KAUFMAN, M
    WILSON, J
    TODO, S
    TZAKIS, A
    [J]. TRANSPLANTATION PROCEEDINGS, 1994, 26 (01) : 173 - 174
  • [8] Letter: future studies of high-dose thiamine should consider whether its effects on fatigue are related to the inhibition of carbonic anhydrase isoenzymes. Authors' reply
    Bager, Palle
    Hvas, Christian
    Rud, Charlotte
    Dahlerup, Jens
    [J]. ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2021, 53 (07) : 853 - 854
1